InvestorsObserver
×
News Home

Is Deciphera Pharmaceuticals Inc (DCPH) a Winner in the Healthcare Sector?

Tuesday, March 26, 2024 12:26 PM | InvestorsObserver Analysts

Mentioned in this article

Is Deciphera Pharmaceuticals Inc (DCPH) a Winner in the Healthcare Sector?

The 65 rating InvestorsObserver gives to Deciphera Pharmaceuticals Inc (DCPH) stock puts it near the top of the Healthcare sector. In addition to scoring higher than 79 percent of stocks in the Healthcare sector, DCPH’s 65 overall rating means the stock scores better than 65 of all stocks.

Overall Score - 65
DCPH has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on DCPH!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 65 means the stock is more attractive than 65 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Deciphera Pharmaceuticals Inc Stock Today?

Deciphera Pharmaceuticals Inc (DCPH) stock has fallen -0.85% while the S&P 500 has risen 0.2% as of 12:24 PM on Tuesday, Mar 26. DCPH is down -$0.13 from the previous closing price of $15.30 on volume of 35,441 shares. Over the past year the S&P 500 is higher by 31.46% while DCPH has risen 1.13%. DCPH lost -$2.29 per share the over the last 12 months. Click Here to get the full Stock Report for Deciphera Pharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App